Abstract
Different types of T effector cells function centrally in the immune-regulatory network, which acts as a line of defense for the body and elicits immune response during any diseased condition. At the molecular level, this functioning is maintained by an intricately designed network of signaling and metabolic pathways that function via multiple cross-talks to regulate complex immune responses during different antigenic challenges. These pathways regulate phenomena such as quiescence exit of naïve T cells, their activation, and differentiation into different effector T cells. Signaling properties of these T cells and their response to different cytokine signals have been well studied. Immune-metabolism is comparatively a new area of research that has been identified as driver for immune response. However, to gain a holistic understanding of the activation and differentiation of naïve T cells into the subtypes, the integration of signaling and metabolic pathway information is a prerequisite. The bidirectional mode of regulation between these cross-talking signaling and metabolic pathways governs the differentiation patterns. In this chapter, we review the activation and differentiation pattern of naïve T cells from both signaling and metabolic perspectives and also look into their cross-talk to understand their mutual regulation during differentiation into effector T cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cruse JM, Lewis RE, Wang H (eds) (2004) Chapter 1 – Molecules, cells, and tissues of immunity. Immunology guidebook. Academic, San Diego, pp 1–15
Rabb H (2002) The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int 61(6):1935–1946
Moticka EJ (2016) Chapter 20 – Activation of T lymphocytes and MHC restriction. A historical perspective on evidence-based immunology. Elsevier, Amsterdam, pp 169–179
Moticka EJ (2016) Chapter 37 – Tumor immunology. A historical perspective on evidence-based immunology. Elsevier, Amsterdam, pp 329–339
Kara EE, Comerford I, Fenix KA, Bastow CR, Gregor CE, McKenzie DR et al (2014) Tailored immune responses: novel effector helper T cell subsets in protective immunity. PLoS Pathog 10(2):e1003905
Moticka EJ (2016) Chapter 23 – T lymphocyte subpopulations. A historical perspective on evidence-based immunology. Elsevier, Amsterdam, pp 197–205
Pearce EL, Pearce EJ (2013) Metabolic pathways in immune cell activation and quiescence. Immunity 38(4):633–643
Zeng H, Chi H (2017) mTOR signaling in the differentiation and function of regulatory and effector T cells. Curr Opin Immunol 46:103–111
Ganeshan K, Chawla A (2014) Metabolic regulation of immune responses. Annu Rev Immunol 32:609–634
Assmann N, Finlay DK (2016) Metabolic regulation of immune responses: therapeutic opportunities. J Clin Invest 126(6):2031–2039
Patel CH, Leone RD, Horton MR, Powell JD (2019) Targeting metabolism to regulate immune responses in autoimmunity and cancer. Nat Rev Drug Discov 18(9):669–688
Jung J, Zeng H, Horng T (2019) Metabolism as a guiding force for immunity. Nat Cell Biol 21(1):85–93
Brownlie RJ, Zamoyska R (2013) T cell receptor signalling networks: branched, diversified and bounded. Nat Rev Immunol 13:257
Ware CF (2008) Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 223:186–201
Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 229(1):152–172
Munroe ME, Bishop GA (2007) A Costimulatory function for T cell CD40. J Immunol 178(2):671–682
Redmond WL, Ruby CE, Weinberg AD (2009) The role of OX40-mediated co-stimulation in T cell activation and survival. Crit Rev Immunol 29(3):187–201
Croft M, So T, Duan W, Soroosh P (2009) The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 229(1):173–191
Ledbetter JA, Deans JP, Aruffo A, Grosmaire LS, Kanner SB, Bolen JB et al (1993) CD4, CD8 and the role of CD45 in T-cell activation. Curr Opin Immunol 5(3):334–340
Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13(4):227–242
Feske S (2007) Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 7:690
Baine I, Abe Brian T, Macian F (2009) Regulation of T-cell tolerance by calcium/NFAT signaling. Immunol Rev 231(1):225–240
Nakaya M, Xiao Y, Zhou X, Chang J-H, Chang M, Cheng X et al (2014) Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40(5):692–705
Palmer CS, Ostrowski M, Balderson B, Christian N, Crowe SM (2015) Glucose metabolism regulates T cell activation, differentiation, and functions. Front Immunol 6:1
Chi H (2012) Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol 12(5):325
Chapman NM, Boothby MR, Chi H (2020) Metabolic coordination of T cell quiescence and activation. Nat Rev Immunol 20:55–70
Johnson MO, Wolf MM, Madden MZ, Andrejeva G, Sugiura A, Contreras DC et al (2018) Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism. Cell 175(7):1780–95.e19
Dodd KM, Tee AR (2012) Leucine and mTORC1: a complex relationship. Am J Physiol Endocrinol Metab 302(11):E1329–42
Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A et al (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ 9(10):1069
Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R et al (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4(12):1206
Geiger R, Rieckmann JC, Wolf T, Basso C, Feng Y, Fuhrer T et al (2016) L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167(3):829–42.e13
Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W et al (2017) ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer 16(1):79
Franchina DG, Dostert C, Brenner D (2018) Reactive oxygen species: involvement in T cell signaling and metabolism. Trends Immunol 39(6):489–502
Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28:445–489
Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4+T cells: differentiation and functions. Clin Dev Immunol 2012:925135
Hawse WF, Cattley RT (2019) T cells transduce T-cell receptor signal strength by generating different phosphatidylinositols. J Biol Chem 294(13):4793–4805
Yamane H, Paul WE (2013) Early signaling events that underlie fate decisions of naive CD4(+) T cells towards distinct T-helper cell subsets. Immunol Rev 252(1):12–23
Peter C, Waldmann H, Cobbold SP (2010) mTOR signalling and metabolic regulation of T cell differentiation. Curr Opin Immunol 22(5):655–661
MacIver NJ, Michalek RD, Rathmell JC (2013) Metabolic regulation of T lymphocytes. Annu Rev Immunol 31:259–283
Klysz D, Tai X, Robert PA, Craveiro M, Cretenet G, Oburoglu L et al (2015) Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. Sci Signal 8(396):ra97
Mak TW, Grusdat M, Duncan GS, Dostert C, Nonnenmacher Y, Cox M et al (2017) Glutathione primes T cell metabolism for inflammation. Immunity 46(4):675–689
Stark JM, Tibbitt CA, Coquet JM (2019) The metabolic requirements of Th2 cell differentiation. Front Immunol 10:2318
Gerriets VA, Kishton RJ, Johnson MO, Cohen S, Siska PJ, Nichols AG et al (2016) Foxp3 and Toll-like receptor signaling balance T reg cell anabolic metabolism for suppression. Nat Immunol 17(12):1459
Angelin A, Gil-de-Gómez L, Dahiya S, Jiao J, Guo L, Levine MH et al (2017) Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Nat Immunol 25(6):1282–93.e7
Geginat J, Paroni M, Maglie S, Alfen JS, Kastirr I, Gruarin P et al (2014) Plasticity of human CD4 T cell subsets. Front Immunol 5:630
Pollizzi KN, Powell JD (2015) Regulation of T cells by mTOR: the known knowns and the known unknowns. Trends Immunol 36(1):13–20
Yang K, Neale G, Green DR, He W, Chi H (2011) The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat Immunol 12(9):888
Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M et al (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 105(22):7797–7802
Macintyre AN, Gerriets VA, Nichols AG, Michalek RD, Rudolph MC, Deoliveira D et al (2014) The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab 20(1):61–72
Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D et al (2011) The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35(6):871–882
Yang K, Shrestha S, Zeng H, Karmaus PW, Neale G, Vogel P et al (2013) T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. Immunity 39(6):1043–1056
Tan H, Yang K, Li Y, Shaw TI, Wang Y, Blanco DB et al (2017) Integrative proteomics and phosphoproteomics profiling reveals dynamic signaling networks and bioenergetics pathways underlying T cell activation. Immunity 46(3):488–503
Gerriets VA, Kishton RJ, Nichols AG, Macintyre AN, Inoue M, Ilkayeva O et al (2015) Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest 125(1):194–207
Blagih J, Coulombe F, Vincent EE, Dupuy F, Galicia-Vázquez G, Yurchenko E et al (2015) The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity 42(1):41–54
Mossmann D, Park S, Hall MN (2018) mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer 18(12):744–757
Buck MD, O’sullivan D, Pearce EL (2015) T cell metabolism drives immunity. J Exp Med 212(9):1345–1360
Mullen PJ, Yu R, Longo J, Archer MC, Penn LZ (2016) The interplay between cell signalling and the mevalonate pathway in cancer. Nat Rev Cancer 16(11):718
Doerig C, Rayner JC, Scherf A, Tobin AB (2015) Post-translational protein modifications in malaria parasites. Nat Rev Microbiol 13(3):160–172
Ho P-C, Bihuniak JD, Macintyre AN, Staron M, Liu X, Amezquita R et al (2015) Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162(6):1217–1228
Wang F, Beck-García K, Zorzin C, Schamel WW, Davis MM (2016) Inhibition of T cell receptor signaling by cholesterol sulfate, a naturally occurring derivative of membrane cholesterol. Nat Immunol 17(7):844–50
Demetriou M, Granovsky M, Quaggin S, Dennis JW (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5N-glycosylation. Nature 409(6821):733–9
Lee K, Gudapati P, Dragovic S, Spencer C, Joyce S, Killeen N et al (2010) Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32(6):743–753
Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR et al (2002) The CD28 signaling pathway regulates glucose metabolism. Immunity 16(6):769–777
Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park J-H et al (2013) IL-7 signaling must be intermittent, not continuous, during CD8+ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol 14(2):143–51
Jacobs SR, Herman CE, MacIver NJ, Wofford JA, Wieman HL, Hammen JJ et al (2008) Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 180(7):4476–4486
Sinclair LV, Rolf J, Emslie E, Shi Y-B, Taylor PM, Cantrell DA (2013) Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol 14(5):500
Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, Chen Y-C et al (2012) A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337(6090):96–100
Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR et al (2011) HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208(7):1367–1376
Sinclair LV, Neyens D, Ramsay G, Taylor PM, Cantrell DA (2018) Single cell analysis of kynurenine and System L amino acid transport in T cells. Nat Commun 9(1):1981
Baixauli F, Acín-Pérez R, Villarroya-Beltrí C, Mazzeo C, Nuñez-Andrade N, Gabandé-Rodriguez E et al (2015) Mitochondrial respiration controls lysosomal function during inflammatory T cell responses. Cell Metab 22(3):485–498
Seman M, Adriouch S, Scheuplein F, Krebs C, Freese D, Glowacki G et al (2003) NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19(4):571–582
Adriouch S, Hubert S, Pechberty S, Koch-Nolte F, Haag F, Seman M (2007) NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo. J Immunol 179(1):186–194
Clever D, Roychoudhuri R, Constantinides MG, Askenase MH, Sukumar M, Klebanoff CA et al (2016) Oxygen sensing by T cells establishes an immunologically tolerant metastatic niche. Cell 166(5):1117–31.e14
Tarasenko TN, Pacheco SE, Koenig MK, Gomez-Rodriguez J, Kapnick SM, Diaz F et al (2017) Cytochrome c oxidase activity is a metabolic checkpoint that regulates cell fate decisions during T cell activation and differentiation. Cell Metab 25(6):1254–68.e7
Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA et al (2013) Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38(2):225–236
Chinen T, Kannan AK, Levine AG, Fan X, Klein U, Zheng Y et al (2016) An essential role for the IL-2 receptor in T reg cell function. Nat Immunol 17(11):1322
Yang K, Blanco DB, Neale G, Vogel P, Avila J, Clish CB et al (2017) Homeostatic control of metabolic and functional fitness of T reg cells by LKB1 signalling. Nature 548(7669):602
Zeiser R, Maas K, Youssef S, Dürr C, Steinman L, Negrin RSJI (2009) Regulation of different inflammatory diseases by impacting the mevalonate pathway. Immunology 127(1):18–25
Huynh A, DuPage M, Priyadharshini B, Sage PT, Quiros J, Borges CM et al (2015) Control of PI (3) kinase in T reg cells maintains homeostasis and lineage stability. Nat Immunol 16(2):188
Tyrakis PA, Palazon A, Macias D, Lee KL, Phan AT, Veliça P et al (2016) S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. Nature 540(7632):236
Kidani Y, Elsaesser H, Hock MB, Vergnes L, Williams KJ, Argus JP et al (2013) Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat Immunol 14(5):489
Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA et al (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134(1):97–111
Angela M, Endo Y, Asou HK, Yamamoto T, Tumes DJ, Tokuyama H et al (2016) Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells. Nat Commun 7:13683
Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D et al (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2, 3-dioxygenase. Immunity 22(5):633–642
Chang C-H, Curtis JD, Maggi LB Jr, Faubert B, Villarino AV, O’Sullivan D et al (2013) Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153(6):1239–1251
Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44–57
Huang DW, Sherman BT, Lempicki RA (2008) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1–13
Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A (2007) GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 8(1):R3
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545–15550
Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G et al (2013) The Reactome pathway knowledgebase. Nucleic Acids Res. 42(D1):D472–D477
Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf Anna C et al (2013) Spatiotemporal dynamics of Intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39(4):782–795
Fridman WH, Pagès F, Sautès-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12:298
Dillon LAL, Suresh R, Okrah K, Corrada Bravo H, Mosser DM, El-Sayed NM (2015) Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions. BMC Genomics 16:1108
Favila MA, Geraci NS, Zeng E, Harker B, Condon D, Cotton RN et al (2014) Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction. J Immunol 192(12):5863–5872
Chowdhury S, Sarkar RR (2015) Comparison of human cell signaling pathway databases—evolution, drawbacks and challenges. Database 2015:bau126
Sherriff MR, Sarkar RR (2008) Computational approaches and modelling of signaling processes in immune system. Proc Indian Natl Sci Acad 74:187–200
Chowdhury S, Sinha N, Ganguli P, Bhowmick R, Singh V, Nandi S et al BIOPYDB: a dynamic human cell specific biochemical pathway database with advanced computational analyses platform. J Integr Bioinform 15(3):20170072
Trupp M, Altman T, Fulcher CA, Caspi R, Krummenacker M, Paley S et al (2010) Beyond the genome (BTG) is a (PGDB) pathway genome database: HumanCyc. Genome Biol 11(1):O12
Schomburg I, Chang A, Schomburg D (2002) BRENDA, enzyme data and metabolic information. Nucleic Acids Res 30(1):47–49
Euler L (1736) Commentarii Academiae Scientiarum Imperialis Petropolitanae 8:128
Watts DJ, Strogatz SH (1998) Collective dynamics of ‘small-world’ networks. Nature 393(6684):440
Barabási A-L, Albert R (1999) Emergence of scaling in random networks. Science 286(5439):509–512
Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T (2010) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27(3):431–432
Bastian M, Heymann S, Jacomy M (2009) Gephi: an open source software for exploring and manipulating networks. Third international AAAI conference on weblogs and social media.
Batagelj V, Mrvar A (1998) Pajek-program for large network analysis. Connect 21(2):47–57
Pavlopoulos GA, Secrier M, Moschopoulos CN, Soldatos TG, Kossida S, Aerts J et al (2011) Using graph theory to analyze biological networks. BioData Min 4(1):10
Bromberg KD, Ma’ayan A, Neves SR, Iyengar R (2008) Design logic of a cannabinoid receptor signaling network that triggers neurite outgrowth. Science 320(5878):903–909
Ghosh S, Kumar GV, Basu A, Banerjee A (2015) Graph theoretic network analysis reveals protein pathways underlying cell death following neurotropic viral infection. Sci Rep 5:14438
Chowdhury S, Pradhan RN, Sarkar RR (2013) Structural and logical analysis of a comprehensive hedgehog signaling pathway to identify alternative drug targets for glioma, colon and pancreatic cancer. PLoS One 8(7):e69132
Chowdhury S, Sarkar R (2013) Drug targets and biomarker identification from computational study of human notch signaling pathway. Clin Exp Pharmacol 3(137):2161–1459
Kauffman SA (1969) Metabolic stability and epigenesis in randomly constructed genetic nets. J Theor Biol 22(3):437–467
Müssel C, Hopfensitz M, Kestler HA (2010) BoolNet—an R package for generation, reconstruction and analysis of Boolean networks. Bioinformatics 26(10):1378–1380
Albert I, Thakar J, Li S, Zhang R, Albert R (2008) Boolean network simulations for life scientists. Source code for biology and medicine. Source Code Biol Med 3(1):16
Klamt S, Saez-Rodriguez J, Gilles ED (2007) Structural and functional analysis of cellular networks with CellNetAnalyzer. BMC Syst Biol 1(1):2
Saez-Rodriguez J, Simeoni L, Lindquist JA, Hemenway R, Bommhardt U, Arndt B et al (2007) A logical model provides insights into T cell receptor signaling. PLOS Comp Biol 3(8):e163
Ganguli P, Chowdhury S, Bhowmick R, Sarkar RR (2015) Temporal protein expression pattern in intracellular signalling cascade during T-cell activation: a computational study. J Biosci 40(4):769–789
Ganguli P, Chowdhury S, Chowdhury S, Sarkar RR (2015) Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach. EURASIP J Bioinform Syst Biol 2015(1):13
Naldi A, Carneiro J, Chaouiya C, Thieffry D (2010) Diversity and plasticity of Th cell types predicted from regulatory network modelling. PLOS Comp Biol 6(9):e1000912
Carbo A, Hontecillas R, Kronsteiner B, Viladomiu M, Pedragosa M, Lu P et al (2013) Systems modeling of molecular mechanisms controlling cytokine-driven CD4+ T cell differentiation and phenotype plasticity. PLOS Comp Biol 9(4):e1003027
Puniya BL, Todd RG, Mohammed A, Brown DM, Barberis M, Helikar T (2018) A mechanistic computational model reveals that plasticity of CD4+ T cell differentiation is a function of cytokine composition and dosage. Front Physiol 9:878
Kelly PN (2019) Metabolism as a driver of immune response. Science 363(6423):137–139
Price ND, Reed JL, Palsson BØ (2004) Genome-scale models of microbial cells: evaluating the consequences of constraints. Nat Rev Microbiol 2(11):886
Blazier AS, Papin JA (2012) Integration of expression data in genome-scale metabolic network reconstructions. Front Physiol 3:299
Orth JD, Palsson BØ (2010) Systematizing the generation of missing metabolic knowledge. Biotechnol Bioeng 107(3):403–412
O’Brien EJ, Monk JM, Palsson BO (2015) Using genome-scale models to predict biological capabilities. Cell 161(5):971–987
Bordbar A, Monk JM, King ZA, Palsson BO (2014) Constraint-based models predict metabolic and associated cellular functions. Nat Rev Genet 15(2):107–120
Patil KR, Nielsen J (2005) Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc Natl Acad Sci U S A 102(8):2685–2689
AbuOun M, Suthers PF, Jones GI, Carter BR, Saunders MP, Maranas CD et al (2009) Genome scale reconstruction of a salmonella metabolic model comparison of similarity and differences with a commensal Escherichia coli strain. J Biol Chem 284(43):29480–29488
Pharkya P, Burgard AP, Maranas CD (2004) OptStrain: a computational framework for redesign of microbial production systems. Genome Res 14(11):2367–2376
Pharkya P, Maranas CD (2006) An optimization framework for identifying reaction activation/inhibition or elimination candidates for overproduction in microbial systems. Metab Eng 8(1):1–13
Förster J, Famili I, Fu P, Palsson BØ, Nielsen J (2003) Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res 13(2):244–253
Orth JD, Thiele I, Palsson BØ (2010) What is flux balance analysis? Nat Biotechnol 28(3):245
Becker SA, Feist AM, Mo ML, Hannum G, Palsson BØ, Herrgard MJ (2007) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat Protoc 2(3):727
Ebrahim A, Lerman JA, Palsson BO, Hyduke DR (2013) COBRApy: constraints-based reconstruction and analysis for python. BMC Syst Biol 7(1):74
Steffensen JL, Dufault-Thompson K, Zhang Y (2016) PSAMM: a portable system for the analysis of metabolic models. PLoS Comput Biol 12(2):e1004732
Rocha I, Maia P, Evangelista P, Vilaça P, Soares S, Pinto JP et al (2010) OptFlux: an open-source software platform for in silico metabolic engineering. BMC Syst Biol 4(1):45
Grafahrend-Belau E, Klukas C, Junker BH, Schreiber F (2009) FBA-SimVis: interactive visualization of constraint-based metabolic models. Bioinformatics 25(20):2755–2757
König M, Holzhütter H-G (2010) Fluxviz—Cytoscape plug-in for visualization of flux distributions in networks. Genome Inform 24:96–103
Marmiesse L, Peyraud R, Cottret L (2015) FlexFlux: combining metabolic flux and regulatory network analyses. BMC Syst Biol 9(1):93
Kirchmair J, Williamson MJ, Afzal AM, Tyzack JD, Choy AP, Howlett A et al (2013) FAst MEtabolizer (FAME): a rapid and accurate predictor of sites of metabolism in multiple species by endogenous enzymes. J Chem Inf Model 53(11):2896–2907
Rowe E, Palsson BO, King ZA (2018) Escher-FBA: a web application for interactive flux balance analysis. BMC Syst Biol 12(1):84
Beerenwinkel N, Schwarz RF, Gerstung M, Markowetz F (2015) Cancer evolution: mathematical models and computational inference. Syst Biol 64(1):e1-25
Banerjee S, Sarkar RR (2008) Delay-induced model for tumor-immune interaction and control of malignant tumor growth. Biosystems 91(1):268–288
d’Onofrio A, Gatti F, Cerrai P, Freschi L (2010) Delay-induced oscillatory dynamics of tumour–immune system interaction. Math Comput Model 51(5–6):572–591
dePillis L, Caldwell T, Sarapata E, Williams H (2013) Mathematical modeling of regulatory T cell effects on renal cell carcinoma treatment. Discrete Cont Dyn-B 18(4):915–943
d’Onofrio A (2008) Metamodeling tumor–immune system interaction, tumor evasion and immunotherapy. Math Comput Model 47(5–6):614–637
Leder K, Pitter K, Laplant Q, Hambardzumyan D, Ross BD, Chan TA et al (2014) Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules. Cell 156(3):603–616
Robertson-Tessi M, El-Kareh A, Goriely A (2012) A mathematical model of tumor-immune interactions. J Theor Biol 294:56–73
Powathil GG, Adamson DJ, Chaplain MA (2013) Towards predicting the response of a solid tumour to chemotherapy and radiotherapy treatments: clinical insights from a computational model. PLoS Comput Biol 9(7):e1003120
Kirschner D, Panetta JC (1998) Modeling immunotherapy of the tumor–immune interaction. JMB 37(3):235–252
de Pillis LG, Radunskaya AE, Wiseman CL (2005) A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Res 65(17):7950
Ganguli P, Sarkar RR (2018) Exploring immuno-regulatory mechanisms in the tumor microenvironment: model and design of protocols for cancer remission. PLoS One 13(9):e0203030
Chew YH, Shia YL, Lee CT, Majid FAA, Chua LS, Sarmidi MR et al (2009) Modeling of glucose regulation and insulin-signaling pathways. Mol Cell Endocrinol 303(1–2):13–24
Reed MC, Thomas RL, Pavisic J, James SJ, Ulrich CM, Nijhout HF et al (2008) A mathematical model of glutathione metabolism. J Theor Biol 5(1):8
Lawley SD, Yun J, Gamble MV, Hall MN, Reed MC, Nijhout HF et al (2014) Mathematical modeling of the effects of glutathione on arsenic methylation. J Theor Biol 11(1):20
Nijhout HF, Best JA, Reed MC (2015) Using mathematical models to understand metabolism, genes, and disease. BMC Biol 13(1):79
Kauffman KJ, Prakash P, Edwards JS (2003) Advances in flux balance analysis. J Coib 14(5):491–496
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Bhowmick, R., Ganguli, P., Sarkar, R.R. (2020). T-Cell Activation and Differentiation: Role of Signaling and Metabolic Cross-Talk. In: Singh, S. (eds) Systems and Synthetic Immunology . Springer, Singapore. https://doi.org/10.1007/978-981-15-3350-1_6
Download citation
DOI: https://doi.org/10.1007/978-981-15-3350-1_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-3349-5
Online ISBN: 978-981-15-3350-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)